scholarly journals American Delusion: Life Expectancy and Welfare in the US from an International Perspective

2021 ◽  
Author(s):  
Rodrigo R. Soares ◽  
Rudi Rocha ◽  
Michel Szklo
2018 ◽  
Vol 8 (1) ◽  
pp. 58-69
Author(s):  
Jyoti Ahluwalia ◽  
Mandeep Mahendru

This case discusses the share buyback announcement by Tata Consultancy Services (TCS) during February 2017 when its Chairman N Chandrasekaran was appointed as the Chairman of Tata Sons after Tata Sons had ousted its former Chairman, Cyrus Mistry. The case highlights the reasons why companies may opt for share buyback, what is the role of the tax laws of the country towards these decisions and whether such decisions are beneficial for the company, the investors or the promoters. The case considers impact of aspects such as employee training and investments in innovation on the buyback decisions and also brings an international perspective with regard to how buybacks have fared in the US during the past decade.


2021 ◽  
Author(s):  
Theresa Andrasfay ◽  
Noreen Goldman

COVID-19 had a huge mortality impact in the US in 2020 and accounted for the majority of the 1.5-year reduction in 2020 life expectancy at birth. There were also substantial racial/ethnic disparities in the mortality impact of COVID-19 in 2020, with the Black and Latino populations experiencing reductions in life expectancy at birth over twice the reduction experienced by the White population. Despite continued vulnerability of the Black and Latino populations, the hope was that widespread distribution of effective vaccines would mitigate the overall impact and reduce racial/ethnic disparities in 2021. In this study, we use cause-deleted life table methods to estimate the impact of COVID-19 mortality on 2021 US period life expectancy. Our partial-year estimates, based on provisional COVID-19 deaths for January-early October 2021 suggest that racial/ethnic disparities have persisted and that life expectancy at birth in 2021 has already declined by 1.2 years from pre-pandemic levels. Our projected full-year estimates, based on projections of COVID-19 deaths through the end of 2021 from the Institute for Health Metrics and Evaluation, suggest a 1.8-year reduction in US life expectancy at birth from pre-pandemic levels, a steeper decline than the estimates produced for 2020. The reductions in life expectancy at birth estimated for the Black and Latino populations are 1.6-2.4 times the impact for the White population.


1993 ◽  
Vol 28 (14) ◽  
pp. 1613-1620
Author(s):  
Donald I. Templer ◽  
Patricia R. Griffin ◽  
Julie Hintze

2021 ◽  
pp. 10.1377/hlthaff
Author(s):  
Keith P. Gennuso ◽  
Elizabeth A. Pollock ◽  
Anne M. Roubal

2021 ◽  
Vol 40 ◽  
pp. 100937
Author(s):  
José Manuel Aburto ◽  
Frederikke Frehr Kristensen ◽  
Paul Sharp
Keyword(s):  

2017 ◽  
Vol 3 ◽  
pp. 808-813 ◽  
Author(s):  
Dana A. Glei ◽  
Noreen Goldman ◽  
Carol D. Ryff ◽  
Maxine Weinstein

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 276-276
Author(s):  
Bin Yu ◽  
Julia Kravchenko

Abstract Racial and geographic disparities in life expectancy (LE) in the US are a persistent problem. We used 5% Medicare Claims for 2000-2017 to investigate the patterns of remaining LE (RLE) in the U.S. with the highest and the lowest LE. RLEs in race-/ethnicity specific populations aged 65+ were calculated in patients with specific diseases and in the total population using the area under the Kaplan-Meier estimator. The Cox model was used to investigate the effect of state-specific residence on total LE and RLE. Between-the-states differences in RLE were most pronounced for cerebrovascular disease, atherosclerotic heart disease, breast and prostate cancer. RLE was the lowest for lung cancer and sepsis, followed by Alzheimer’s disease, dementia, pneumonia, and heart failure. RLE for myocardial infarction and cerebrovascular disease decreased over time, while for renal failure, diabetes, atherosclerotic heart disease, and cancers of breast and prostate RLE increased.


Sign in / Sign up

Export Citation Format

Share Document